Biopharmaceutical/Biotech

Access thought leadership from YourEncore Experts on the Biopharmaceutical & Biotech industry.

  • The Path to Patient Centricity: Part I

    The Path to Patient Centricity: Part I

    Learn more from Regina Shanklin on how seeing things from the patient’s point-of-view will help you meet them where they are and increase the relevance of your brand communications

    Read Article
  • ×

    Subscribe to receive YourEncore Thought Leadership straight to your inbox!

    First Name
    Last Name
    Are you a YourEncore Expert or interested in becoming one?
    Thank you!
    Error - something went wrong!
  • How Smart Biotechs Scale Organizations Fast and Maximize Value48:10

    How Smart Biotechs Scale Organizations Fast and Maximize Value

    Watch Video
  • Managing the Talent Roller Coaster with Virtual Development Models

    Managing the Talent Roller Coaster with Virtual Development Models

    Raphael G. Ognar discusses the overlying challenges biopharma organizations have and how Virtual Development can save the day.

    Read Article
  • Embracing the Virtual Development Model in Biopharma

    Embracing the Virtual Development Model in Biopharma

    Joseph Lamendola, PhD discusses the challenges many biopharma companies face and how Virtual Development can help create solutions.

    Read Article
  • A Kickstart for Your Development Programs

    A Kickstart for Your Development Programs

    Joseph Lamendola, PhD and Timothy Franson, MD walk through the requirements for kickstarting a new development program in a Biopharma organization.

    Read Article
  • Leveraging the Evolving Regulatory Landscape to Accelerate Drug & Medical Devices Development

    Leveraging the Evolving Regulatory Landscape to Accelerate Drug & Medical Devices Development

    The Food & Drug Administration has actively engaged in efforts to issue new regulations and guidance aimed at driving innovation, reducing risk, and improving patient safety.

    Read Article
  • Improving R&D Productivity with Activity Based Costing

    Improving R&D Productivity with Activity Based Costing

    Today’s prevailing wisdom is that R&D costs are on the rise while ROI on those investments are down. The Tufts Center for the Study of Drug Development puts the total costs of new drug around...

    Read Article
  • How Blockchain is Revolutionizing the World and Changing Healthcare as We Know It (Ep. 20 of The Pharmcast)

    How Blockchain is Revolutionizing the World and Changing Healthcare as We Know It (Ep. 20 of The Pharmcast)

        In this episode of The Pharmcast, we join YourEncore Expert, Darryl Glover, to discuss one of the hottest technologies on the market today: blockchain. We've heard some people...

    Read Article
  • Ten Tips for Enterprise Technology Adoption in Pharma

    Ten Tips for Enterprise Technology Adoption in Pharma

    The RFP processes are robust, the ROI models are compelling, the software is best of breed, and the expectations are high. So, why do so many software deployment programs in Pharma fail...

    Read Article
  • [WEBINAR] Process Mapping: The First Step in Unlocking Supply Chain Value43:10

    [WEBINAR] Process Mapping: The First Step in Unlocking Supply Chain Value

    Watch Video
  • State of the Industry: U.S. Regulatory Policy Improvements (Ep. 19 of The Pharmcast)

    State of the Industry: U.S. Regulatory Policy Improvements (Ep. 19 of The Pharmcast)

      In this episode of The Pharmcast, we share a recording from our May 5th webinar, State of the Industry: U.S. Regulatory Policy Overview. Parthenon-EY and YourEncore recently...

    Read Article
  • ×

    Subscribe to receive YourEncore Thought Leadership straight to your inbox!

    First Name
    Last Name
    Are you a YourEncore Expert or interested in becoming one?
    Thank you!
    Error - something went wrong!
  • The Frontiers of Rare Disease Development: Advances in Regulatory Science with Dr. Tim Franson (Ep. 18 of The Pharmcast)

    The Frontiers of Rare Disease Development: Advances in Regulatory Science with Dr. Tim Franson (Ep. 18 of The Pharmcast)

      This week on The Pharmcast, we catch up with Dr. Tim Franson to discuss the leading edge of rare disease drug development. Dr. Franson has been actively helping Parent Project...

    Read Article
  • [WEBINAR] State of the Industry Webinar:  U.S. Regulatory Policy Improvements56:51

    [WEBINAR] State of the Industry Webinar: U.S. Regulatory Policy Improvements

    Watch Video
  • YourEncore Pharm-ers Almanac 2015 [WHITE PAPER]

    YourEncore Pharm-ers Almanac 2015 [WHITE PAPER]

    View Content
  • 7 Best Practices in Biologics Launch Communications (Ep. 16 of The Pharmcast)

    7 Best Practices in Biologics Launch Communications (Ep. 16 of The Pharmcast)

      On this episode of The Pharmcast, Heidi Youngkin shares seven best practices for successful biologic launch communication. When it costs over $2.5B dollars to develop a drug,...

    Read Article
  • The Future is Here: Using Big Data and Artificial Intelligence in Oncology (Ep. 15 of The Pharmcast)

    The Future is Here: Using Big Data and Artificial Intelligence in Oncology (Ep. 15 of The Pharmcast)

    On this week's episode of The Pharmcast, we talk with YourEncore Expert, Philippe Barzin, on the future of big data and artificial intelligence in oncology. Based off Philippe's...

    Read Article
  • Working with the FDA: Developing a Regulatory Strategy That Works (Ep. 14 of The Pharmcast)

    Working with the FDA: Developing a Regulatory Strategy That Works (Ep. 14 of The Pharmcast)

    On this week's episode of The Pharmcast, we explore the key elements of an effective regulatory strategy and how to drive value to patient and shareholders by working with the FDA. We...

    Read Article
  • Riding the Policy Roller Coaster in 2017: A Policy Update with Dr. Tim Franson (Ep. 13 of The Pharmcast)

    Riding the Policy Roller Coaster in 2017: A Policy Update with Dr. Tim Franson (Ep. 13 of The Pharmcast)

    We are at a time of great change and transition in the FDA. The sitting FDA chief stepped down, just when the 21st Century Cures Act passed into law; PDUFA 6 is up for renewal this...

    Read Article
  • NDA Mistakes to Avoid: An Interview with Dr. Joseph Lamendola (Ep. 12 on The Pharmcast)

    NDA Mistakes to Avoid: An Interview with Dr. Joseph Lamendola (Ep. 12 on The Pharmcast)

    Read Article
  • Patient Engagement: Putting Rare Disease Patients First (Ep. 10 on The Pharmcast)

    Patient Engagement: Putting Rare Disease Patients First (Ep. 10 on The Pharmcast)

    This week on The Pharmcast, we turn our attention to the topic of rare disease, and more specifically: how to engage and educate rare disease patients to advance development. It's...

    Read Article
  • loading
    Loading More...